HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 26.18
Day range
kr 24.08 - kr 26.94
Year range
kr 22.34 - kr 57.30
Market cap
1.65B SEK
Avg Volume
307.43K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 32.34M | -35.85% |
Operating expense | 192.52M | -7.37% |
Net income | -276.42M | -122.10% |
Net profit margin | -854.81 | -246.23% |
Earnings per share | -4.08 | -72.88% |
EBITDA | -172.96M | 1.07% |
Effective tax rate | -1.04% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 405.28M | -44.64% |
Total assets | 800.64M | -21.35% |
Total liabilities | 1.39B | 17.21% |
Total equity | -589.32M | — |
Shares outstanding | 67.81M | — |
Price to book | -3.01 | — |
Return on assets | -49.87% | — |
Return on capital | -76.92% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -276.42M | -122.10% |
Cash from operations | -206.84M | -19.60% |
Cash from investing | — | — |
Cash from financing | 57.16M | 2,704.19% |
Net change in cash | -148.26M | 15.81% |
Free cash flow | -210.52M | -248.46% |
About
Founded
2007
Website
Employees
135
